This article is more than 5 years old. Information may no longer be current.
Radiotherapy treatment for wet AMD to be offered at Swiss clinic
Click Here to Manage Email Alerts
EyeRAD and Oraya Therapeutics will soon offer the noninvasive, low-energy X-ray Oraya Therapy for the treatment of wet age-related macular degeneration at a clinic in Switzerland, according to a news release.
The one-time, outpatient stereotactic radiotherapy procedure, intended to reduce or eliminate the need for anti-VEGF injections, will be available at the Vista Klinik in Basel.
The treatment met safety and efficacy endpoints in the sham-controlled, double-masked phase 3 INTREPID trial, completed in 21 sites across five countries in Europe. Researchers found a 32% reduction in frequency of anti-VEGF injections among patients who received Oraya Therapy compared to those in the control group.
No loss of best corrected visual acuity and no radiation retinopathy or other severe adverse events were reported in the trial.